Abstract
Abstract
Objective
To assess the registration quality of traditional Chinese medicine (TCM) clinical trials for COVID-19, H1N1, and SARS.
Method
We searched for clinical trial registrations of TCM in the WHO International Clinical Trials Registry Platform (ICTRP) and Chinese Clinical Trial Registry (ChiCTR) on April 30, 2020. The registration quality assessment is based on the WHO Trial Registration Data Set (Version 1.3.1) and extra items for TCM information, including TCM background, theoretical origin, specific diagnosis criteria, description of intervention, and outcomes.
Results
A total of 136 records were examined, including 129 severe acute respiratory syndrome coronavirus 2 (COVID-19) and 7 H1N1 influenza (H1N1) patients. The deficiencies in the registration of TCM clinical trials (CTs) mainly focus on a low percentage reporting detailed information about interventions (46.6%), primary outcome(s) (37.7%), and key secondary outcome(s) (18.4%) and a lack of summary result (0%). For the TCM items, none of the clinical trial registrations reported the TCM background and rationale; only 6.6% provided the TCM diagnosis criteria or a description of the TCM intervention; and 27.9% provided TCM outcome(s).
Conclusion
Overall, although the number of registrations of TCM CTs increased, the registration quality was low. The registration quality of TCM CTs should be improved by more detailed reporting of interventions and outcomes, TCM-specific information, and sharing of the result data.
Funder
Guangdong Provincial Key Laboratory of Research on Emergency in TCM
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Medicine (miscellaneous)
Reference32 articles.
1. Tai-xiang WU, You-ping LI, Xun YAO, Jing LI. Clinical trial registration: to improve the quality of clinical research in China. Chin J Evid-based Med. 2006;03:153–6. https://doi.org/10.3969/j.issn.1672-2531.2006.03.001 Chinese.
2. DeAngelis CD, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. JAMA. 2004;292(11):1363–4. https://doi.org/10.1001/jama.292.11.1363.
3. Tai-xiang WU, You-ping LI, Jing LI, Guan-jian LIU. A milestone for clinical trials: the global clinical trial registration system lauched up. Chin J Evid-based Med. 2007;07:479–80. https://doi.org/10.3969/j.issn.1672-2531.2007.07.001 Chinese.
4. Tai-xiang WU, Minawear ABUDU, Yuan HAO, Xiang-yu KONG, Shuo CHEN, You-ping LI. The past 10 years of clinical trial registration in China: status and challenge. Chin J Evid-based Med. 2018;18(06):522–5 Chinese.
5. Emergency regulations for public health emergencies. Available from: http://www.gov.cn/zhengce/zhengceku/2008-03/28/content_6399.htm. [Accessed 30 Apr 2020].